Maropitant

Jump to navigation Jump to search
Maropitant
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral, subcutaneous
ATCvet code
Legal status
Legal status
  • Veterinary use only
Identifiers
PubChem CID
ChemSpider
UNII
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC32H40N2O
Molar mass468.67 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Maropitant

Articles

Most recent articles on Maropitant

Most cited articles on Maropitant

Review articles on Maropitant

Articles on Maropitant in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Maropitant

Images of Maropitant

Photos of Maropitant

Podcasts & MP3s on Maropitant

Videos on Maropitant

Evidence Based Medicine

Cochrane Collaboration on Maropitant

Bandolier on Maropitant

TRIP on Maropitant

Clinical Trials

Ongoing Trials on Maropitant at Clinical Trials.gov

Trial results on Maropitant

Clinical Trials on Maropitant at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Maropitant

NICE Guidance on Maropitant

NHS PRODIGY Guidance

FDA on Maropitant

CDC on Maropitant

Books

Books on Maropitant

News

Maropitant in the news

Be alerted to news on Maropitant

News trends on Maropitant

Commentary

Blogs on Maropitant

Definitions

Definitions of Maropitant

Patient Resources / Community

Patient resources on Maropitant

Discussion groups on Maropitant

Patient Handouts on Maropitant

Directions to Hospitals Treating Maropitant

Risk calculators and risk factors for Maropitant

Healthcare Provider Resources

Symptoms of Maropitant

Causes & Risk Factors for Maropitant

Diagnostic studies for Maropitant

Treatment of Maropitant

Continuing Medical Education (CME)

CME Programs on Maropitant

International

Maropitant en Espanol

Maropitant en Francais

Business

Maropitant in the Marketplace

Patents on Maropitant

Experimental / Informatics

List of terms related to Maropitant

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Maropitant (trade name Cerenia in the US and other countries), used as maropitant citrate (USAN), is a neurokinin (NK1) receptor antagonist, which was developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs. It was approved by the FDA in 2007 for use in dogs,[1][2] and more recently has also been approved for use in cats.[3]

Maropitant also has anti-nociceptive (analgesic) properties. In a 2012 study, parenteral maropitant decreased the minimum alveolar concentration (MAC) of sevoflurane in a pain-response model.[citation needed] Epidural administration had no effect. It has also been shown to decrease the MAC of sevoflurane in a cat spay and dog spay model. Whether it has analgesic properties in awake animals remains to be proven, but anecdotal evidence indicates that it is being used for analgesia by many veterinarians.

References

  1. "Cerenia (maropitant citrate) Injectable Solution, Dogs" (pdf). Retrieved 2011-04-19.
  2. Package Insert for Cerenia at Pfizer Animal Health (full detailed drug information)
  3. "Cerenia (maropitant citrate) information at Pfizer Animal Health".

External links

  • Cerenia: Official Page
  • Cerenia: Product Information at Vet Label
  • FDA: Adverse Drug Experience (ADE) Reports: See Maropitant (multiple sections, p. 121-152)
  • Boscan P, Monnet E, Mama K; et al. (2011). "Maropitant an NK-1 Antagonist Decreases the Anesthetic Requirements During Visceral Stimulation of the Ovary in Dogs". Am J Vet Res. 72: 1576–1579.
  • Boscan P, Monnet E, Mama K; et al. (2011). "A dog model to study ovary, ovarian ligament and visceral pain". Veterinary Anesthesia and Analgesia. 38: 260–266.
  • Niyom S, Boscan P, Twedt DC; et al. (2013). "Effect of maropitant, a neurokinin-1 receptor antagonist, on the minimum alveolar concentration of sevoflurane during stimulation of the ovarian ligament in cats". Vet Anaesth Analg. 40: 425–431.

Template:Antiemetics and antinauseants Template:Neuropeptide agonists and antagonists